drugset / Trial / NCT03593538
Effects of Metformin During Nicotine Withdrawal
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to test the effects of a medication called metformin (Glucophage®) on smoking behavior. This medication is FDA-approved for treatment of type-2 diabetes. It is being used for research purposes in this study. Participants will be randomized to one of 3 treatment groups: low dose of metformin, high dose of metformin, or placebo.
Timeline
- Start
- 2016-04-01
- Primary completion
- 2020-03-13
- Completion
- 2020-03-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | 500 mg | — |
| Subject | Metformin | Small molecule | 1500 mg | — |